StockpollyBeta
Get App
Popularity #4,392
BCDA · NASDAQ · Biotechnology

BioCardia (BCDA)

Develops cell therapies and catheter systems for heart and lung diseases.

$1.09
After hours+0.04 (+3.32%)
At close$1.06(−2.31%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000000000000
Cost of revenue211101210000
Gross profit−2−1−1−10−1−2−10000
111121111221
Research & development211111211111
000010000111
General & administrative000000000001
Other expenses−10000−10−10000
Operating income−3−2−2−2−2−2−3−2−1−2−2−2
000000000000
Other non-operating income000000000000
Income before tax−3−2−2−2−2−2−3−2−1−2−2−2
Net income from continuing operations−3−2−2−2−2−2−3−2−1−2−2−2
Net income−3−2−2−2−2−2−3−2−1−2−2−2
EPS, basic−$1.79−$1.38−$1.35−$0.88−$0.61−$0.84−$0.99−$0.40−$0.24−$0.18−$0.21−$0.13
EPS, diluted−$1.79−$1.38−$1.35−$0.88−$0.61−$0.50−$0.99−$0.40−$0.24−$0.18−$0.21−$0.13
Weighted average shares, basic122233356111112
Weighted average shares, diluted122233356111112
EBITDA−3−2−2−2−2−2−3−2−1−2−2−1
Depreciation & amortization000000000000
EBIT−3−2−2−2−2−2−3−2−1−2−2−2